Cargando…

Antireflux Endoluminal Therapies: Past and Present

The basic principle of antireflux procedures employing endoscopic intervention aims to create a mechanical barrier to prevent primary pathophysiology in gastroesophageal reflux disease (GERD). We review, highlight, and discuss the past and present status of endoluminal therapy. Currently, there are...

Descripción completa

Detalles Bibliográficos
Autores principales: Yew, Kuo Chao, Chuah, Seng-Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723090/
https://www.ncbi.nlm.nih.gov/pubmed/23935608
http://dx.doi.org/10.1155/2013/481417
_version_ 1782278256870817792
author Yew, Kuo Chao
Chuah, Seng-Kee
author_facet Yew, Kuo Chao
Chuah, Seng-Kee
author_sort Yew, Kuo Chao
collection PubMed
description The basic principle of antireflux procedures employing endoscopic intervention aims to create a mechanical barrier to prevent primary pathophysiology in gastroesophageal reflux disease (GERD). We review, highlight, and discuss the past and present status of endoluminal therapy. Currently, there are 3 commonly employed anti-reflux endoluminal procedures: fundoplication or suturing techniques (EndoCinch, NDO, and EsophyX), intramural injection or implant techniques (enhancing lower esophageal sphincter (LES) volume and/or strengthening compliance of the LES-Enteryx and Gatekeeper), and radiofrequency ablation of LES and cardia. EndoCinch plication requires further study and modification of technique before it can be recommended because of durability issues. Esophynx, the transoral incisionless fundoplication, may reduce hiatal hernias and increase LES length. Preliminary studies have shown promising reduction in symptoms and medication use but evidence concerning safety and long-term durability is still pending. The safety issue with injection technique is the main concern as evident from the incidences of implant withdrawals after reported major adverse events. Future research with cautious monitoring is required before any new implant material can be recommended for commercial application. Radiofrequency ablation therapy is regaining popularity in treating refractory symptoms despite PPI use due to improved efficacy, durability, and safety after years of refinement of protocol.
format Online
Article
Text
id pubmed-3723090
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37230902013-08-09 Antireflux Endoluminal Therapies: Past and Present Yew, Kuo Chao Chuah, Seng-Kee Gastroenterol Res Pract Review Article The basic principle of antireflux procedures employing endoscopic intervention aims to create a mechanical barrier to prevent primary pathophysiology in gastroesophageal reflux disease (GERD). We review, highlight, and discuss the past and present status of endoluminal therapy. Currently, there are 3 commonly employed anti-reflux endoluminal procedures: fundoplication or suturing techniques (EndoCinch, NDO, and EsophyX), intramural injection or implant techniques (enhancing lower esophageal sphincter (LES) volume and/or strengthening compliance of the LES-Enteryx and Gatekeeper), and radiofrequency ablation of LES and cardia. EndoCinch plication requires further study and modification of technique before it can be recommended because of durability issues. Esophynx, the transoral incisionless fundoplication, may reduce hiatal hernias and increase LES length. Preliminary studies have shown promising reduction in symptoms and medication use but evidence concerning safety and long-term durability is still pending. The safety issue with injection technique is the main concern as evident from the incidences of implant withdrawals after reported major adverse events. Future research with cautious monitoring is required before any new implant material can be recommended for commercial application. Radiofrequency ablation therapy is regaining popularity in treating refractory symptoms despite PPI use due to improved efficacy, durability, and safety after years of refinement of protocol. Hindawi Publishing Corporation 2013 2013-07-09 /pmc/articles/PMC3723090/ /pubmed/23935608 http://dx.doi.org/10.1155/2013/481417 Text en Copyright © 2013 K. C. Yew and S.-K. Chuah. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Yew, Kuo Chao
Chuah, Seng-Kee
Antireflux Endoluminal Therapies: Past and Present
title Antireflux Endoluminal Therapies: Past and Present
title_full Antireflux Endoluminal Therapies: Past and Present
title_fullStr Antireflux Endoluminal Therapies: Past and Present
title_full_unstemmed Antireflux Endoluminal Therapies: Past and Present
title_short Antireflux Endoluminal Therapies: Past and Present
title_sort antireflux endoluminal therapies: past and present
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723090/
https://www.ncbi.nlm.nih.gov/pubmed/23935608
http://dx.doi.org/10.1155/2013/481417
work_keys_str_mv AT yewkuochao antirefluxendoluminaltherapiespastandpresent
AT chuahsengkee antirefluxendoluminaltherapiespastandpresent